TECHNOLOGICAL APPLICATIONS OF NEW ANTI-NEPOLASTICI (Q2031397)

From EU Knowledge Graph
Revision as of 09:00, 15 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
Jump to navigation Jump to search
Project Q2031397 in Italy
Language Label Description Also known as
English
TECHNOLOGICAL APPLICATIONS OF NEW ANTI-NEPOLASTICI
Project Q2031397 in Italy

    Statements

    0 references
    84,000.0 Euro
    0 references
    168,000.0 Euro
    0 references
    50.0 percent
    0 references
    22 July 2016
    0 references
    30 April 2019
    0 references
    UFF_EFATTURAPA
    0 references
    0 references

    45°40'37.52"N, 13°45'12.31"E
    0 references
    IL PROGETTO PREVEDE LO STUDIO IN VITRO SU CULTURE PRIMARIE E LINEE CELLULARI DELLA TOSSICITà DEI SISTEMI DI DRUG DELIVERY SVILUPPATI DA NEALYS (B1) E L'EFFICACIA DEL TARGETTING SELETTIVO. SUCCESSIVAMENTE I SISTEMI SELEZIONATI E CARICATI CON FARMACI ANTITUMORALI SARANNO TESTATI IN VITRO SU LINEE CELLULARI DI CARCINOMA OVARICO. INOLTRE, A PARTIRE DA BIOPSIE DI TUMORE OVARICO DI PAZIENTE SARANNO ALLESTITE COLTURE ORGANOTIPICHE ED ESPERIMENTI DI XENOGRAFT IN MODELLI ANIMALI PER VALIDARE LE MOLECOL (Italian)
    0 references
    THE PROJECT PROVIDES FOR AN IN VITRO STUDY ON PRIMARY CULTURES AND CELL LINES OF THE DRUG DELIVERY SYSTEMS DEVELOPED BY NEALYS (B1) AND THE EFFECTIVENESS OF THE SELECTIVE TARGETING SYSTEM. SUBSEQUENTLY, SYSTEMS SELECTED AND UPLOADED WITH CANCER DRUGS WILL BE TESTED IN VITRO ON OVARIAN CANCER LINES. IN ADDITION, FROM BIOPSIES OF OVARIAN CANCER, ORGANIOTIPITA CULTURES AND EXPERIMENTS OF XENMOGRAPHY WILL BE ESTABLISHED IN ANIMALS MODELS FOR THE VALIDATION OF MOLCOL. (English)
    0 references
    LE PROJET COMPREND L’ÉTUDE IN VITRO DES CULTURES PRIMAIRES ET DES LIGNÉES CELLULAIRES DES SYSTÈMES D’ADMINISTRATION DE MÉDICAMENTS MIS AU POINT PAR NEALYS (B1) ET L’EFFICACITÉ DU CIBLAGE SÉLECTIF. PAR LA SUITE, LES SYSTÈMES SÉLECTIONNÉS ET CHARGÉS DE MÉDICAMENTS ANTICANCÉREUX SERONT TESTÉS IN VITRO SUR DES LIGNÉES CELLULAIRES DU CANCER DE L’OVAIRE. EN OUTRE, DES CULTURES ORGANOTYPIQUES ET DES EXPÉRIENCES DE XÉNOGREFFE DANS DES MODÈLES ANIMAUX SERONT MISES EN PLACE À PARTIR DE BIOPSIES DU CANCER DE L’OVAIRE PATIENTE POUR VALIDER LES MOLÉCULES. (French)
    15 December 2021
    0 references

    Identifiers

    C92F17000310007
    0 references